Risk factors for the development of post-transplant lymphoproliferative disorder in a large animal model

American Journal of Transplantation

Volumn 4, Issue 8, 2004, Pages 1274-1282

  Cho, Patricia S ^a   Mueller, Nicolas J ^a   Cameron, Andrew M ^a   Cina, Robert A ^a   Coburn, Rebecca C ^a   Hettiaratchy, Shehan ^a   Melendy, Elizabeth ^a   Neville, David M ^b   Patience, Clive ^c   Fishman, Jay A ^a   Sachs, David H ^a   Huang, Christene A ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c Immerge Biotherapeutics Inc   (United States)

Author keywords

Hematopoietic cell transplantation; Immunosuppression; Miniature swine; Porcine lymphotrophic herpes virus; Post transplant lymphoproliferative disease

Indexed keywords

CD3 ANTIGEN; CYCLOSPORIN A; IMMUNOTOXIN; INTERLEUKIN 3; STEM CELL FACTOR;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FLOW CYTOMETRY; HAPLOTYPE; HERPES VIRUS; HLA MATCHING; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE DEPLETION; LYMPHOPROLIFERATIVE DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PORCINE LYMPHOTROPHIC HERPES VIRUS; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; RISK FACTOR; SWINE; T LYMPHOCYTE; VIRUS LOAD;

EID: 3543037014     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00506.x     Document Type: Article

References (39)

1. Swinnen LJ. Diagnosis and treatment of transplant-related lymphoma. Ann Oncol 2000; 11: 45-48.
2. Paya CV, Fung JJ, Nalesnik MA et al. Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting, Transplantation 1999; 68: 1517-1525.
3. McKhann CF. Primary malignancy in patients undergoing immunosuppression for renal transplantation. Transplantation 1969; 8: 209-212.
4. Younes BS, McDiarmid SV, Martin MG et al. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. Transplantation 2000; 70: 94-99.
5. Curtis RE, Travis LB, Rowlings PA et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999; 94: 2208-2216.
6. Gross TG, Steinbuch M, DeFor T et al. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome. Bone Marrow Transplant 1999; 23: 251-258.
7. Johannessen I, Crawford DH. In vivo models for Epstein-Barr virus (EBV)-associated B cell lymphoproliferative disease (BLPD). Rev Med Virol 1999; 9: 263-277.
8. Moghaddam A, Rosenzweig M, Lee-Parritz D, Annis B, Johnson RP, Wang F. An animal model for acute and persistent Epstein-Barr virus infection. Science 1997; 276: 2030-2033.
9. Falk L, Deinhardt F, Wolfe L, Johnson D, Hilgers J, de The G. Epstein-Barr virus: experimental infection of Callithrix jacchus marmosets. Int J Cancer 1976; 17: 785-788.
10. Shope T, Dechairo D, Miller G. Malignant lymphoma in cottontop marmosets after inoculation with Epstein-Barr virus. Proc Natl Acad Sci U S A 1973; 70: 2487-2491.
11. Schmidtko J, Wang R, Wu CL et al. Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys. Transplantation 2002; 73: 1431-1439.
12. Huang CA, Fuchimoto Y, Gleit ZL et al. Posttransplant lymphoproliferative disease in miniature swine after allogeneic hematopoietic cell transplantation: similarity to human PTLD and association with a porcine gammaherpesvirus. Blood 2001; 97: 1467-1473.
13. Fuchimoto Y, Huang CA, Yamada K et al. Mixed chimerism and tolerance without whole body irradiation in a large animal model. J Clin Invest 2000; 105: 1779-1789.
14. Gleit ZL, Fuchimoto Y, Yamada K et al. Variable relationship between chimerism and tolerance following hematopoietic cell transplantation without myelosuppressive conditioning in miniature swine. Transplantation 2002; 74: 1535-1544.
15. Goltz M, Ericsson T, Patience C et al. Sequence analysis of the genome of porcine lymphotropic herpesvirus 1 and gene expression during posttransplant lymphoproliferative disease of pigs. Virology 2002; 294: 383-393.
16. Sachs DH, Leight G, Cone J, Schwartz S, Stuart L, Rosenberg S. Transplantation in miniature swine. I. Fixation of the major histocompatibility complex. Transplantation 1976; 22: 559-567.
17. Sachs DH. MHC homozygous miniature swine. In: Swindle MM, Moody DC, Phillips LD, eds. Swine as Models in Biomedical Research, Ames, Iowa: Iowa State University Press, 1992: 3-15.
18. Fuchimoto Y, Huang CA, Shimizu A, Seebach J, Arn JS, Sachs DH. An allelic non-histocompatibility antigen with wide tissue distribution as a marker for chimerism in pigs. Tissue Antigens 1999; 54: 43-52.
19. Huang CA, Fuchimoto Y, Scheier-Dolberg R, Murphy MC, Neville DM Jr, Sachs DH. Stable mixed chimerism and tolerance using a nonmyeloablative preparative regimen in a large-animal model. J Clin Invest 2000; 105: 173-181.
20. Huang CA, Yamada K, Murphy MC et al. In vivo T cell depletion in miniature swine using the swine CD3 immunotoxin, pCD3-CRM9. Transplantation 1999; 68: 855-860.
21. Huang CA, Lorf T, Arn JS, Koo GC, Blake T, Sachs DH. Characterization of a monoclonal anti-porcine CD3 antibody. Xenotransplant 1999; 5: 201-212.
22. Pescovitz MD, Lunney JK, Sachs DH. Preparation and characterization of monoclonal antibodies reactive with porcine PBL. J Immunol 1984; 133: 368-375.
23. Mueller NJ, Barth RN, Yamamoto S et al. Activation of cytomegalovirus in pig-to-primate organ xenotransplantation. J Virol 2002; 76: 4734-4740.
24. Ehlers B, Ulrich S, Goltz M. Detection of two novel porcine herpesviruses with high similarity to gammaherpesviruses. J Gen Virol 1999; 80: 971-978.
25. Sullivan JA, Oettinger HF, Sachs DH, edge, AS Analysis of polymorphism in porcine MHC class I genes: alterations in signals recognized by human cytotoxic lymphocytes. J Immunol 1997; 159: 2318-2326.
26. Gleit ZL, Cameron AM, Fuchimoto Y et al. Persistent chimerism despite anti-donor MHC in vitro responses in miniature swine following allogeneic hematopoietic cell transplantation. Transplantation 2002; 74: 1260-1266.
27. Lima B, Gleit ZL, Cameron AM et al. Engraftment of quiescent progenitors and conversion to full chimerism following nonmyelosuppressive conditioning and hematopoietic cell transplantation in miniature swine. Biol Blood Marrow Transplant 2003; 9: 571-582.
28. Talpe S, Oike F, Dehoux JP et al. Posttransplant lymphoproliferative disorder after liver transplantation in miniature swine. Transplantation 2001; 71: 1684-1688.
29. Cockfield SM. Identifying the patient at risk for post-transplant lymphoproliferative disorder. Transpl Infect Dis 2001; 3: 70-78.
30. Rowe DT, Webber S, Schauer EM, Reyes J, Green M. Epstein-Barr virus load monitoring: its role in the prevention and management of post-transplant lymphoproliferative disease. Transpl Infect Dis 2001; 3: 79-87.
31. Rooney CM, Smith CA, Ng CY et al. Infusion of cytotoxic T cells for the prevention and treatment of Epstein-Barr virus-induced lymphoma in allogeneic transplant recipients. Blood 1998; 92: 1549-1555.
32. Cockfield SM, Preiksaitis JK, Jewell LD, Parfrey NA. Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center. Transplantation 1993; 56: 88-96.
33. Swinnen LJ, Costanzo-Nordin MR, Fisher SG et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1990; 323: 1723-1728.
34. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342: 1514-1516.
35. Walker RC, Paya CV, Marshall WF et al. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations. J Heart Lung Transplant 1995; 14: 214-221.
36. Meijer E, Slaper-Cortenbach IC, Thijsen SF, Dekker AW, Verdonck LF. Increased incidence of EBV-associated lymphoproliferative disorders after allogeneic stem cell transplantation from matched unrelated donors due to a change of T cell depletion technique. Bone Marrow Transplant 2002; 29: 335-339.
37. Witherspoon RP, Fisher LD, Schoch G et al. Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med 1989; 321: 784-789.
38. Sen-Majumdar A, Guidos C, Kina T, Lieberman M, Weissman IL. Characterization of preneoplastic thymocytes and of their neoplastic progression in irradiated C57BL/Ka mice. J Immunol 1994; 153: 1581-1592.
39. Boulton E, Cleary H, Plumb M, Myeloid, B and T lymphoid and mixed lineage thymic lymphomas in the irradiated mouse. Carcinogenesis 2002; 23: 1079-1085.